Page last updated: 2024-09-03

ly 293558 and Injury, Ischemia-Reperfusion

ly 293558 has been researched along with Injury, Ischemia-Reperfusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bowes, MP; Swanson, S; Zivin, JA	1

Other Studies

1 other study(ies) available for ly 293558 and Injury, Ischemia-Reperfusion

Article	Year
The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1996, Volume: 16, Issue:5 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Blood Pressure; Ischemia; Ischemic Attack, Transient; Isoquinolines; Kinetics; Male; Paraplegia; Rabbits; Reperfusion Injury; Spinal Cord; Tetrazoles	1996

Article

Year

The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1996, Volume: 16, Issue:5

Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Blood Pressure; Ischemia; Ischemic Attack, Transient; Isoquinolines; Kinetics; Male; Paraplegia; Rabbits; Reperfusion Injury; Spinal Cord; Tetrazoles

1996